23andMe has introduced a new polygenic risk score report for osteoporosis, which helps customers understand their likelihood of developing the condition and provides actionable lifestyle recommendations.

23andMe Research Institute is a nonprofit medical research organization that enables people everywhere to access their genetic information, learn about themselves and participate in the world's largest crowdsourced research initiative. The Institute aims to be the world's most significant contributor to scientific advancement, uniting people with the common goal of improving health and deepening our understanding of DNA — the code of life. 



23andMe Holding Co. Launches New Polygenic Risk Score Report on Osteoporosis for 23andMe+ Premium Members.

Product Description

Company Information

Product Launch Insights

Related People

23andMe Holding Co. Launches New Polygenic Risk Score Report on Osteoporosis for 23andMe+ Premium Members.

Product Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Product Launch Insights

Related People

Company Information